Restricting Access To Medication Abortion Will Not Help Survivors Of Intimate Partner Violence

Forefront Group 2026 Dataset

View at publisher
Authors: Elizabeth Tobin‐Tyler, Kari White, Maeve E Wallace, Samuel Dickman
DOI: 10.1377/forefront.20260224.327464
Cited by: 0

Abstract

The FDA should protect continued access to mifepristone—one of two medications used for abortion—not only based on the undeniable scientific evidence affirming its safety, but also because it will save the lives of survivors of intimate partner violence.

Fields of Study & Subjects

Reproductive Health and Contraception Intimate Partner and Family Violence International Human Rights and Reproductive Law

Publication details

Journal / source
Forefront Group
Publication date
26 February 2026
Language
EN
Document type
Dataset